Table 2.
Number of Patients (N = 827) | ||
---|---|---|
Pathologic Tumor Stage
| ||
ypT0 | 174 | 21.0% |
ypT1 | 46 | 5.6% |
ypT2 | 251 | 30.4% |
ypT3 | 332 | 40.1% |
ypT4 | 24 | 2.9% |
| ||
Pathologic Node Stage
| ||
ypN0 | 631 | 76.3% |
ypN1 | 152 | 18.4% |
ypN2 | 44 | 5.3% |
| ||
Pathologic Stage
| ||
Stage 0 | 165 | 20.0% |
Stage I | 246 | 29.7% |
Stage II | 220 | 26.6% |
Stage III | 196 | 23.7% |
| ||
Tumor Response
| ||
<50% | 160 | 19.3% |
50 - 75% | 181 | 21.9% |
75 - 90% | 189 | 22.9% |
> 90% | 259 | 31.3% |
Unknown | 38 | 4.6% |